Skip to main content

Table 2 Characteristics of 1-month survivors and non-survivors among patients with sepsis

From: Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients

 

Survivors (n = 130)

Non-survivors (n = 68)

P-value

Gender, male, n (%)

89 (68.5)

41 (60.3)

0.27

Age, years, median ( 25th, 75th percentile)

54 (44, 64)

61 (50, 72)

0.11

Diabetes mellitus, n (%)

33 (25.4)

24 (35.3)

0.19

COPD, n (%)

15 (11.5)

9 (13.2)

0.82

Ischemic heart disease, n (%)

13 (10.0)

7 (10.3)

0.99

Chronic renal failure, n (%)

6 (4.6)

7 (10.3)

0.14

Site of infection, n (%)

  

0.40

  Respiratory

72 (55.4)

40 (58.8)

 

  Abdominal

39 (30.0)

18 (26.5)

 

  Neurological

2 (1.5)

1 (1.5)

 

  Urinary

8 (6.2)

2 (2.9)

 

  Skin

6 (4.6)

1 (1.5)

 

  Endocarditis

3 (2.3)

5 (7.3)

 

  Osteomyelitis

0

1 (1.5)

 

Microorganism responsible, n (%)

   

  Unknown

68 (52.3)

35 (51.5)

0.99

  Gram-positive

28 (21.5)

19 (27.9)

0.38

  Gram-negative

32 (24.6)

14 (20.6)

0.60

  Fungii

3 (2.3)

3 (4.4)

0.42

  Anaerobe

1 (0.8)

1 (1.5)

0.99

Bloodstream infection, n (%)

20 (15.4)

11 (16.2)

0.99

Empiric antimicrobial treatment, n (%)

  

0.89

  Unknown if adequate due to negative cultures

65 (50.0)

33 (48.5)

 

  Unknown if adequate due to diagnosis by antigenuria

4 (3.1)

3 (4.4)

 

  Adequate

55 (42.3)

30 (44.1)

 

  Inadequate

6 (4.6)

2 (2.9)

 

Betalactamic more aminoglycoside, n (%)

26 (20.0)

16 (23.5)

0.59

Aminoglycoside, n (%)

36 (27.7)

18 (26.5)

0.99

Betalactamic more quinolone, n (%)

70 (53.8)

36 (52.9)

0.99

Septic shock, n (%)

109 (83.8)

62 (91.2)

0.19

PaO2/FIO2 ratio, median (25th, 75th percentile)

159 (105, 260)

168 (109, 237)

0.58

Creatinine, mg/dl , median (25th, 75th percentile)

1.10 (0.80, 1.90)

1.60 (0.90, 2.65)

0.08

Bilirubin, mg/dl, median (25th, 75th percentile)

0.90 (0.40, 1.55)

0.88 (0.47, 2.54)

0.63

Leukocytes, cells/μl, median*103 (25th, 75th percentile)

14.0 (8.6, 21.5)

15.1 (6.4, 20.2)

0.84

Lactic acid, mmol/l, median (25th, 75th percentile)

1.80 (1.20, 3.50)

3.80 (1.55, 6.25)

<0.001

Platelets, cells/μl, median*103 (25th, 75th percentile)

192 (112, 267)

124 (64, 196)

0.01

INR, median (25th, 75th percentile)

1.26 (1.10, 1.50)

1.42 (1.15, 1.68)

0.03

aPTT, seconds, median (25th, 75th percentile)

32 (28, 37)

38 (29, 45)

0.01

APACHE-II score, median (25th, 75th percentile)

18 (14, 23)

23 (17, 28)

<0.001

SOFA score, median (25th, 75th percentile)

9 (7, 12)

11 (9, 14)

0.001

  1. COPD, chronic obstructive pulmonary disease; PaO2/FIO2, pressure of arterial oxygen/fraction inspired oxygen; INR, international normalized ratio; aPTT, activated partial thromboplastin time; APACHE, acute physiology and chronic health evaluation; SOFA, sepsis-related organ failure assessment.